2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Colorectal Neoplasms
442
Rectal Neoplasms
209
Colonic Neoplasms
202
Pancreatic Neoplasms
133
Stomach Neoplasms
117
Neoplasm Metastasis
97
Neoplasms
64
Esophageal Neoplasms
57
Precursor Cell Lymphoblastic Leukemia-Lymphoma
51
Lymphoma
49
Leukemia
41
Carcinoma, Hepatocellular
41
Adenocarcinoma Of Esophagus
37
Burkitt Lymphoma
33
Adenocarcinoma
29
Cholangiocarcinoma
27
Biliary Tract Neoplasms
23
Carcinoma, Non-Small-Cell Lung
21
Gastrointestinal Neoplasms
20
Gallbladder Neoplasms
20
Lymphoma, Non-Hodgkin
19
Esophageal Squamous Cell Carcinoma
15
Osteosarcoma
14
Liver Neoplasms
14
Bile Duct Neoplasms
14
Unspecified Adult Solid Tumor, Protocol Specific
13
Lymphoma, Large B-Cell, Diffuse
13
Leukemia, Biphenotypic, Acute
13
Ovarian Neoplasms
12
Leukemia, Myeloid, Acute
12
Interventions
Dexamethasone
13
Bortezomib
8
Cyclophosphamide
6
Lenalidomide
5
pomalidomide
3
isatuximab
3
glucarpidase
3
Kidney Transplantation
3
Calcium Dobesilate
3
Thalidomide
2
Paclitaxel
2
Gemcitabine
2
Carboplatin
2
Blood Specimen Collection
2
Bendamustine Hydrochloride
2
Azacitidine
2
vinflunine
1
veliparib
1
trifluridine tipiracil drug combination
1
trebananib
1
safinamide
1
sacubitril and valsartan sodium hydrate drug combination
1
rubitecan
1
ripretinib
1
regorafenib
1
pevonedistat
1
pembrolizumab
1
osimertinib
1
mirabegron
1
melflufen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Renal Insufficiency
×
Leucovorin
×
Clear all
NCT00634504
2022-06-06
LVPK
BTG International Inc.
Phase 1
Completed
20 enrolled
9 charts